Literature DB >> 3295159

Persistent tubular resistance to aldosterone in infants with congenital hydronephrosis corrected neonatally.

G Marra, V Goj, A C Appiani, C A Dell Agnola, S A Tirelli, B Tadini, U Nicolini, G Cavanna, B M Assael.   

Abstract

Renal function of 18 infants who had undergone surgery in the neonatal period because of severe congenital hydronephrosis was followed up for 5 to 36 months (mean +/- SD 21 +/- 10 months). In all cases the diagnosis was made prenatally by sonography and confirmed at birth by intravenous urography. Creatinine clearance developed normally in all the children. Eight had a reduction in maximal urinary concentrating ability after intranasal DDAVP; this defect was transient and resolved after 4 to 5 months in all but one child, in whom it persisted. However, other tubular abnormalities were present. Throughout the observation period, patient serum potassium concentrations were significantly higher than normal, paralleled by a significant increase in plasma aldosterone concentration but with normal excretion fraction of sodium and potassium. There were no disturbances of acid-base balance. These findings may be accounted for by a persistent partial reduced sensitivity of the distal tubule to the action of aldosterone despite normal renal function. This alteration is usually mild, but may constitute a persistent metabolic risk despite successful surgical intervention.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3295159     DOI: 10.1016/s0022-3476(87)80398-0

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  11 in total

1.  Salt-losing crisis in infants-not always of adrenal origin.

Authors:  Bharathi Pai; Nick Shaw; Wolfgang Högler
Journal:  Eur J Pediatr       Date:  2011-08-11       Impact factor: 3.183

2.  Case 2: Hyponatremia and hyperkalemia in a four-week-old boy.

Authors:  Mb Peddle; G Joubert; R Lim
Journal:  Paediatr Child Health       Date:  2008-05       Impact factor: 2.253

3.  Urosepsis in infants with vesicoureteral reflux masquerading as the salt-losing type of congenital adrenal hyperplasia.

Authors:  Y N Vaid; R L Lebowitz
Journal:  Pediatr Radiol       Date:  1989

4.  Increased sodium requirement following early postnatal surgical correction of congenital uropathies in infants.

Authors:  F Terzi; B M Assael; A Claris-Appiani; G Marra; C A Dell'Agnola; B Tadini; V Tomaselli
Journal:  Pediatr Nephrol       Date:  1990-11       Impact factor: 3.714

5.  Age-dependent renal expression of acid-base transporters in neonatal ureter obstruction.

Authors:  Guixian Wang; Sukru Oguzkan Topcu; Troels Ring; Jianguo Wen; Jens Christian Djurhuus; Tae-Hwan Kwon; Søren Nielsen; Jørgen Frøkiaer
Journal:  Pediatr Nephrol       Date:  2009-06-03       Impact factor: 3.714

Review 6.  Transient type 1 pseudo-hypoaldosteronism: report on an eight-patient series and literature review.

Authors:  Radovan Bogdanović; Natasa Stajić; Jovana Putnik; Aleksandra Paripović
Journal:  Pediatr Nephrol       Date:  2009-11       Impact factor: 3.714

7.  Rare causes of acute hyperkalemia in the 1st week of life. Three case reports.

Authors:  Vasilios I Giapros; Agathoklis A Tsatsoulis; Ekaterini A Drougia; Konstantinos D Kollios; Ekaterini C Siomou; Styliani K Andronikou
Journal:  Pediatr Nephrol       Date:  2004-06-04       Impact factor: 3.714

Review 8.  Renal tubular hyperkalaemia in childhood.

Authors:  J Rodríguez-Soriano; A Vallo
Journal:  Pediatr Nephrol       Date:  1988-10       Impact factor: 3.714

Review 9.  Prostanoids in paediatric kidney diseases.

Authors:  H W Seyberth; A Leonhardt; B Tönshoff; N Gordjani
Journal:  Pediatr Nephrol       Date:  1991-09       Impact factor: 3.714

Review 10.  Na(+), K(+), Cl(-), acid-base or H2O homeostasis in children with urinary tract infections: a narrative review.

Authors:  Anna Bertini; Gregorio P Milani; Giacomo D Simonetti; Emilio F Fossali; Pietro B Faré; Mario G Bianchetti; Sebastiano A G Lava
Journal:  Pediatr Nephrol       Date:  2015-12-23       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.